NCT00197587 - Prevention of Milk-Borne Transmission of HIV-1C in Botswana | Biotech Hunter

Enrollment

1,200

Participants

Timeline

Start Date

August 31, 2002

Primary Completion Date

May 31, 2005

Conditions

HIV InfectionInfant Risk for HIV Infection by MTCT

Interventions

DRUG

Nevirapine

All women received a background of zidovudine from 34 weeks' gestation through delivery, and all infants received single-dose nevirapine at birth and zidovudine from birth through 1 month. Women were randomized to receive either single-dose nevirapine or placebo during labor.

DRUG

No intervention

All women received a background of zidovudine from 34 weeks'gestation through delivery, and all infants received single-dose nevirapine at birth and zidovudine from birth through 1 month. Women were randomized to receive either single-dose nevirapine or placebo during labor.

All Listed Sponsors

lead

Harvard School of Public Health (HSPH)

OTHER